4//SEC Filing
Mingozzi Federico 4
Accession 0001609351-19-000029
CIK 0001609351other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:18 PM ET
Size
13.5 KB
Accession
0001609351-19-000029
Insider Transaction Report
Form 4
Mingozzi Federico
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2018-06-26$87.98/sh−2,627$231,123→ 5,748 total - Exercise/Conversion
Restricted Stock Units
2018-06-26−8,375→ 25,125 total→ Common Stock (8,375 underlying) - Exercise/Conversion
Common Stock
2018-06-26+8,375→ 8,375 total - Exercise/Conversion
Common Stock
2019-01-18+2,000→ 7,748 total - Exercise/Conversion
Restricted Stock Units
2019-01-18−2,000→ 6,000 total→ Common Stock (2,000 underlying) - Tax Payment
Common Stock
2019-01-18$45.08/sh−733$33,044→ 7,015 total
Footnotes (4)
- [F1]Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock.
- [F3]On September 29, 2017, the reporting person was granted 33,500 restricted stock units to vest in four equal installments. The first installment vested June 26, 2018 with the remaining three installments vesting annually thereafter. Vested shares will be delivered to the reporting person annually on the vesting date.
- [F4]On January 18, 2018, the reporting person was granted 8,000 restricted stock units that vest in four equal annual installments beginning January 18, 2019. Vested shares will be delivered to the reporting person annually on the vesting date.
Documents
Issuer
Spark Therapeutics, Inc.
CIK 0001609351
Entity typeother
Related Parties
1- filerCIK 0001732126
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:18 PM ET
- Size
- 13.5 KB